ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG
Product details
Registration number: SIN15192P
Classification: Prescription Only
Active ingredients: Sterile Aripiprazole monohydrate 416mg/vial equivalent to anhydrous Aripiprazole
Strength: 400mg/vial
Dosage form: INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE
Route: INTRAMUSCULAR
Registrant: OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.
ATC code: N05AX12
HSA approval date: 14 March 2017
Manufacturer(s):
- Otsuka Pharmaceutical Co.Ltd
- Siegfried Hameln GmbH (Water for Injection)
- Otsuka Pharmaceutical Co., Ltd.
Manufacturing country/countries: GERMANY; JAPAN
What are the HSA registration number and classification for ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15192P
Classification: Prescription Only
What active ingredients and strength are recorded for ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Sterile Aripiprazole monohydrate 416mg/vial equivalent to anhydrous Aripiprazole
Strength: 400mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE
Route: INTRAMUSCULAR
Who is the recorded registrant for ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Otsuka Pharmaceutical Co.Ltd
- Siegfried Hameln GmbH (Water for Injection)
- Otsuka Pharmaceutical Co., Ltd.
Manufacturing country/countries: GERMANY; JAPAN
Where can I look up ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15192P or the exact product name ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG. The general register link does not preselect this product.
What are the source dates for this ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15192P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)